Abstract:Objective: To investigate CMV-pp65 antigenemia in hepatitis B virus(HBV) related hepatocellular carcinoma patients and discuss the clinical significance of CMV-pp65 antigen detcetion.Methods: Immunohistochemistry two-step method and enzyme-linked immunosorbent assay(ELISA) were used to detect the CMV-pp65 antigen and CMV-specific IgM antibodies in 30 cases of HBV related hepatocellular carcinoma patients;Simultaneously the CMV-pp65 antigen of 18 healthy volunteers were detected as a control group.Chi-square test was used for statistical analysis.Results: The positive rate of CMV-pp65 antigen in HBV related hepatocellular carcinoma patients was 43.3%(13/30);while the positive rate of CMV-specific IgM antibodies was 6.7%(2/30).The difference had significance in statistics(χ2=10.756,P0.01).In Healthy control group,0 in 18 cases was CMV-pp65 antigen positive.The difference was of significance in statistics(χ2=10.697,P 0.01).Conclusion: Hepatitis B virus related hepatocellular carcinoma patients have high positive rate of CMV-pp65 antigenemia,suggesting active CMV infection;CMV-IgM antibody is not suitable for the early diagnosis of active CMV infection in patients with hepatocellular carcinoma.

The clinical significance of CMV - pp65 antigen detcetion in hepatitis B virus (HBV) related hepatocellular carcinoma patients